Streamlining eligibility assessment for Alzheimer's disease-modifying therapies: Prediction of MMSE scores using the digital clock and recall - Top-Institutions - MDSpire

Streamlining eligibility assessment for Alzheimer's disease-modifying therapies: Prediction of MMSE scores using the digital clock and recall

  • By

  • Ali Jannati

  • Claudio Toro-Serey

  • Marissa Ciesla

  • Emma Chen

  • John Showalter

  • David Bates

  • Alvaro Pascual-Leone

  • Sean Tobyne

  • July 9, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Bio-Hermes-001
    Bio-Hermes-001

    Unknown, Unknown

    Key Differentiators

    • Neurology

  • #2

    Apheleia study
    Apheleia study

    Unknown, Unknown

    Key Differentiators

    • Neurology

  • #3

    Davos Alzheimer's Collaborative
    Davos Alzheimer's Collaborative

    Unknown, Unknown

    Key Differentiators

    • Neurology

Original Source(s)

Streamlining eligibility assessment for Alzheimer's disease-modifying therapies: Prediction of MMSE scores using the digital clock and recall

  • by Ali Jannati, Claudio Toro-Serey, Marissa Ciesla, Emma Chen, John Showalter, David Bates, Alvaro Pascual-Leone, Sean Tobyne

  • July 9, 2026

Related Content

Most common, burdensome, and worrisome symptoms experienced by people living with early Parkinson’s disease in Germany and the United States—Results from a cross-sectional survey

A deep learning approach for acoustic-based identification of muscle tension dysphonia and spasmodic dysphonia

Long-term alterations in pain sensitivity following preterm birth: a systematic review and meta-analysis